169 related articles for article (PubMed ID: 38594742)
21. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
Huang CY; Chang RF; Lin CY; Hsieh MS; Liao PC; Wang YJ; Kao YC; Porta L; Lin PY; Lee CC; Lee YH
Histopathology; 2024 May; 84(6):983-1002. PubMed ID: 38288642
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
Tang W; Xu F; Zhao M; Zhang S
BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
[TBL] [Abstract][Full Text] [Related]
24. Co-existing malignant lesions in atypical ductal hyperplasia - Pathology, probability, predictors and prognosis.
Co M; Shek T; Kwong A
Asian J Surg; 2020 Jan; 43(1):240-243. PubMed ID: 31130499
[TBL] [Abstract][Full Text] [Related]
25. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
[TBL] [Abstract][Full Text] [Related]
26. Quantitative Assessment of Restriction Spectrum MR Imaging for the Diagnosis of Breast Cancer and Association With Prognostic Factors.
Qin Y; Tang C; Hu Q; Zhang Y; Yi J; Dai Y; Ai T
J Magn Reson Imaging; 2023 Jun; 57(6):1832-1841. PubMed ID: 36205354
[TBL] [Abstract][Full Text] [Related]
27. Construction and validation of an immunity-related prognostic signature for breast cancer.
Zhu T; Zheng J; Hu S; Zhang W; Zhou H; Li X; Liu ZQ
Aging (Albany NY); 2020 Nov; 12(21):21597-21612. PubMed ID: 33216733
[TBL] [Abstract][Full Text] [Related]
28. Development of a novel prognostic signature based on single-cell combined bulk RNA analysis in breast cancer.
Xiao Y; Hu G; Xie N; Yin L; Pan Y; Liu C; Lou S; Zhu C
J Gene Med; 2024 Feb; 26(2):e3673. PubMed ID: 38404059
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of a Novel Plasma Protein Signature for Breast Cancer Diagnosis by Using Multiple Reaction Monitoring-based Mass Spectrometry.
Lee HB; Kang UB; Moon HG; Lee J; Lee KM; Yi M; Park YS; Lee JW; Yu JH; Choi SH; Cho SH; Lee C; Han W; Noh DY
Anticancer Res; 2015 Nov; 35(11):6271-9. PubMed ID: 26504062
[TBL] [Abstract][Full Text] [Related]
30. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
Costa MJ; Tadros T; Hilton G; Birdsong G
Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
[TBL] [Abstract][Full Text] [Related]
32. Validation of 70-gene prognosis signature in node-negative breast cancer.
Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
[TBL] [Abstract][Full Text] [Related]
33. Integrative multi-omics analyses unravel the immunological implication and prognostic significance of CXCL12 in breast cancer.
Gao ZJ; Fang Z; Yuan JP; Sun SR; Li B
Front Immunol; 2023; 14():1188351. PubMed ID: 37564657
[TBL] [Abstract][Full Text] [Related]
34. [Application of diffusion weighted magnetic resonance imaging to differential diagnosis of breast diseases].
Luo JD; Liu YY; Zhang XL; Shi LC
Ai Zheng; 2007 Feb; 26(2):168-71. PubMed ID: 17298747
[TBL] [Abstract][Full Text] [Related]
35. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
36. Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.
Martin KJ; Patrick DR; Bissell MJ; Fournier MV
PLoS One; 2008 Aug; 3(8):e2994. PubMed ID: 18714348
[TBL] [Abstract][Full Text] [Related]
37. A fine-needle aspiration-based protein signature discriminates benign from malignant breast lesions.
Franzén B; Kamali-Moghaddam M; Alexeyenko A; Hatschek T; Becker S; Wik L; Kierkegaard J; Eriksson A; Muppani NR; Auer G; Landegren U; Lewensohn R
Mol Oncol; 2018 Sep; 12(9):1415-1428. PubMed ID: 30019538
[TBL] [Abstract][Full Text] [Related]
38. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
[TBL] [Abstract][Full Text] [Related]
39. [Value of vacuum assisted biopsies under sonography guidance: results from a multicentric study of 650 lesions].
Sebag P; Tourasse C; Rouyer N; Lebas P; Dénier JF; Michenet P
J Radiol; 2006 Jan; 87(1):29-34. PubMed ID: 16415777
[TBL] [Abstract][Full Text] [Related]
40. Expression of survivin and clinical correlation in patients with breast cancer.
Sohn DM; Kim SY; Baek MJ; Lim CW; Lee MH; Cho MS; Kim TY
Biomed Pharmacother; 2006 Jul; 60(6):289-92. PubMed ID: 16876381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
